- 全部删除
 
您的购物车当前为空
Droloxifene (3-Hydroxytamoxifen),Tamoxifen 衍生物,是一种具有口服活性和选择性的雌激素受体 (estrogen receptor) 调节剂。Droloxifene 具有抗雌激素和抗植入作用。Droloxifene 诱导 MCF-7 细胞 p53 表达及凋亡。Droloxifene 预防去卵巢大鼠骨丢失。

Droloxifene (3-Hydroxytamoxifen),Tamoxifen 衍生物,是一种具有口服活性和选择性的雌激素受体 (estrogen receptor) 调节剂。Droloxifene 具有抗雌激素和抗植入作用。Droloxifene 诱导 MCF-7 细胞 p53 表达及凋亡。Droloxifene 预防去卵巢大鼠骨丢失。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 496  | In stock | |
| 5 mg | ¥ 1,180  | In stock | |
| 10 mg | ¥ 1,780  | In stock | |
| 25 mg | ¥ 2,940  | In stock | |
| 50 mg | ¥ 4,130  | In stock | |
| 100 mg | ¥ 5,570  | In stock | |
| 500 mg | ¥ 10,900  | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,360  | In stock | 
Droloxifene 相关产品
| 产品描述 | Droloxifene (3-Hydroxytamoxifen), a tamoxifen derivative, is an oral active and selective estrogen receptor modulator.Droloxifene induced p53 expression and apoptosis in McF-7 cells.Fluroxifene has anti-estrogen and anti-implantation effects.Fluroxifene prevented bone loss in ovariectomized rats.  | 
| 体外活性 | Droloxifene在MCF-7细胞中诱导凋亡作用(10 nM;16-18小时)[1]。  | 
| 体内活性 | Droloxifene 在 (5-20毫克/公斤,P.o.,每天给药至4周)可将迪氟醯胺(DFM)的骨密度(BMD)提高至10mg/kg。Droloxifene 在20mg/kg/天的剂量下完全阻止卵巢切除(OVX)导致DFM的骨矿含量(BMC)及BMD降低[1]。  | 
| 别名 | 屈洛昔芬, 3-Hydroxytamoxifen | 
| 分子量 | 387.51 | 
| 分子式 | C26H29NO2 | 
| CAS No. | 82413-20-5 | 
| Smiles | CC\C(=C(\c1ccc(OCCN(C)C)cc1)c1cccc(O)c1)c1ccccc1 | 
| 密度 | 1.16. Temperature:20 °C. | 
| 颜色 | White | 
| 物理性状 | Solid | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 40 mg/mL (103.22 mM), Sonication is recommended.   | |||||||||||||||||||||||||||||||||||
溶液配制表  | ||||||||||||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||||||||||||
评论内容